Mortality and appropriate and inappropriate therapy in patients with ischaemic heart disease and implanted cardioverter-defibrillators for primary prevention: Data from the Danish ICD Register

Europace

Volumn 15, Issue 8, 2013, Pages 1150-1157

  Weeke, Peter ^a,b   Johansen, Jens Brock ^c   Jørgensen, Ole Dan ^c   Nielsen, Jens Cosedis ^d   Møller, Mogens ^c   Videbæk, Regitze ^e   Højgaard, Michael Vinther ^a   Riahi, Sam ^f   Jacobsen, Peter Karl ^e  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b VANDERBILT UNIVERSITY   (United States)

^c ODENSE UNIVERSITY HOSPITAL   (Denmark)

^d AARHUS UNIVERSITY HOSPITAL   (Denmark)

^e UNIVERSITY OF COPENHAGEN   (Denmark)

^f AALBORG UNIVERSITY HOSPITAL   (Denmark)

Author keywords

CRT D; ICD; Ischaemic heart disease; Primary prevention

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; ELECTRIC SHOCK; FEMALE; FOLLOW UP; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIMARY PREVENTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; SUDDEN CARDIAC DEATH;

EID: 84880947455     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eut017     Document Type: Article

References (30)

1. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997; 337:1576-83
2. Connolly SJ, Gent M, Roberts RS, Dorian P, Roy D, Sheldon RS et al. Canadian implantable defibrillator study (CIDS): A randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 2000;101: 1297-302
3. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005;352:225-37
4. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-83
5. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 1999;341:1882-90
6. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): Developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: Endorsed by the Heart Rhythm Society. Circulation 2005;112: E154-235
7. Scott PA, Turner NG, Chungh A, Morgan JM, Roberts PR. Varying implantable cardioverter defibrillator referral patterns from implanting and non-implanting hospitals. Europace 2009;11:1048-51
8. Tung R, Zimetbaum P, Josephson ME. A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death. J Am Coll Cardiol 2008;52:1111-21
9. Katritsis DG, Josephson ME. Sudden cardiac death and implantable cardioverter defibrillators: Two modern epidemics? Europace 2012;14:787-94
10. Dewland TA, Pellegrini CN, Wang Y, Marcus GM, Keung E, Varosy PD. Dualchamber implantable cardioverter-defibrillator selection is associated with increased complication rates and mortality among patients enrolled in the NCDR implantable cardioverter-defibrillator registry. J Am Coll Cardiol 2011;58: 1007-13
11. Lee DS, Krahn AD, Healey JS, Birnie D, Crystal E, Dorian P et al. Evaluation of early complications related to De Novo cardioverter defibrillator implantation insights from the Ontario ICD database. J Am Coll Cardiol 2010;55:774-82
12. Danish Pacemaker and ICD Register. http://www.pacemaker.dk (1 January 2012, date last accessed
13. Macfadden DR, Crystal E, Krahn AD, Mangat I, Healey JS, Dorian P et al. Sex differences in implantable cardioverter-defibrillator outcomes: Findings from a prospective defibrillator database. Ann Intern Med 2012;156:195-203
14. Wathen MS, DeGroot PJ, Sweeney MO, Stark AJ, Otterness MF, Adkisson WO et al. Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (PainFREE Rx II) trial results. Circulation 2004;110: 2591-6
15. Retningslinjer for profylaktisk ICD Behandling. Guidelines for Prophylactic ICD Therapy. http://cardio.dk/rapporter/kliniske (7 July 2011, date last accessed
16. Braunschweig F, Boriani G, Bauer A, Hatala R, Herrmann-Lingen C, Kautzner J et al. Management of patients receiving implantable cardiac defibrillator shocks: Recommendations for acute and long-Term patient management. Europace 2010; 12:1673-90
17. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 1996;335:1933-40
18. Clementy N, Pierre B, Lallemand B, Marie O, Lemoine E, Cosnay P et al. Longterm follow-Up on high-rate cut-off programming for implantable cardioverter defibrillators in primary prevention patients with left ventricular systolic dysfunction. Europace 2012;14:968-74
19. Martins RP, Blangy H, Muresan L, Freysz L, Groben L, Zinzius PY et al. Safety and efficacy of programming a high number of antitachycardia pacing attempts for fast ventricular tachycardia: A prospective study. Europace 2012;14: 1457-64
20. Moss AJ, Schuger C, Beck CA, Brown MW, Cannom DS, Daubert JP et al. Reduction in inappropriate therapy and mortality through ICD programming. N Engl J Med 2012;367:2275-83
21. Kadish A, Dyer A, Daubert JP, Quigg R, Estes NA, Anderson KP et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 2004;350:2151-8
22. Almendral J, Arribas F, Wolpert C, Ricci R, Adragao P, Cobo E et al. Dualchamber defibrillators reduce clinically significant adverse events compared with single-chamber devices: Results from the DATAS (Dual chamber and Atrial Tachyarrhythmias Adverse Events Study) trial. Europace 2008;10: 528-35
23. Dorian P, Philippon F, Thibault B, Kimber S, Sterns L, Greene M et al. Randomized controlled study of detection enhancements versus rate-only detection to prevent inappropriate therapy in a dual-chamber implantable cardioverterdefibrillator. Heart Rhythm 2004;1:540-7
24. Deisenhofer I, Kolb C, Ndrepepa G, Schreieck J, Karch M, Schmieder S et al. Do current dual chamber cardioverter defibrillators have advantages over conventional single chamber cardioverter defibrillators in reducing inappropriate therapies? A randomized, prospective study. J Cardiovasc Electrophysiol 2001;12: 134-42
25. Friedman PA, McClelland RL, Bamlet WR, Acosta H, Kessler D, Munger TM et al. Dual-chamber versus single-chamber detection enhancements for implantable defibrillator rhythm diagnosis: The detect supraventricular tachycardia study. Circulation 2006;113:2871-9
26. Worck R, Haarbo J, Thomsen PE. Electrophysiological study and 'slow' ventricular tachycardia predict appropriate therapy: Results from a single-centre implantable cardiac defibrillator follow-Up. Europace 2007;9:1048-53
27. Poole JE, Johnson GW, Hellkamp AS, Anderson J, Callans DJ, Raitt MH et al. Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med 2008;359:1009-17
28. Hohnloser SH, Kuck KH, Dorian P, Roberts RS, Hampton JR, Hatala R et al. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med 2004;351:2481-8
29. Myerburg RJ. Implantable cardioverter-defibrillators after myocardial infarction. N Engl J Med 2008;359:2245-53
30. Moller M, Arnsbo P, Asklund M, Christensen PD, Gadsboll N, Svendsen JH et al. Quality assessment of pacemaker implantations in Denmark. Europace 2002;4: 107-12